Steve Wolk. Characterization of gRNAs and Ribonucleoproteins for CRISPR Applications. Presented at TIDES USA Oligonucleotide and Peptide Therapeutics, September 20-23, 2021.

Mar

20

Editas Medicine Announces Chief Financial Officer Transition

Mar

5

Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates

Feb

24

Editas Medicine to Announce Fourth Quarter/Full Year 2024 Financial Results and to Participate in Investor Conferences in March